Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-25

Clinical Trial Update: Fecal Microbiota Transplantation to Treat Recurrent C. Difficile Associated Diarrhea Via Retention Enema or Oral Route [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/Phase 2 clinical trial evaluating fecal microbiota transplantation via retention enema or oral route for recurrent Clostridioides difficile i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: C. Difficile | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-03-25